www.ozmrs.com/2023-agm/202...
#metastasisresearch #cancerresearch
www.ozmrs.com/2023-agm/202...
#metastasisresearch #cancerresearch
We've developed a new patient-derived model of a rare cancer, TFCP2-rearranged intraosseous rhabdomyosarcoma, and validated a promising preclinical treatment approach for this disease.
doi.org/10.1158/1535...
We've developed a new patient-derived model of a rare cancer, TFCP2-rearranged intraosseous rhabdomyosarcoma, and validated a promising preclinical treatment approach for this disease.
doi.org/10.1158/1535...
More info on eligibility and how to apply: metastasis-research.org/for-research...
📅 First Round Deadline: 1st May 2025
#Metastasis #ECR #CancerResearch #TravelBursary
More info on eligibility and how to apply: metastasis-research.org/for-research...
📅 First Round Deadline: 1st May 2025
#Metastasis #ECR #CancerResearch #TravelBursary
Thank you @garvaninstitute.bsky.social for the outfits!
Thank you @garvaninstitute.bsky.social for the outfits!